How do we implement ANNEXXa-I into our Clinical Practice?

November 30, 2023

For acute care physicians, anticoagulated patients presenting with intracranial hemorrhage (ICH) is an incredibly challenging clinical scenario. ANNEXa-I is a randomized, controlled, clinical trial which provides clinicians with important information on appropriate reversal of anticoagualtion to optimally care for these patients.

0 Comments

Tweet Share

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

July 28, 2023

Real World studies can provide the foundational support necessary for clinicians to effectively manage anticoagulated patients with severe, often life-threatening intracranial and gastrointestinal bleeding. While randomized controlled clinical trials have provided the initial data necessary for appropriate use of reversal agents such as andexanet alfa for Factor Xa associated bleeding, broader studies enrolling thousands of patients, many with significant co-morbidities, are extremely valuable to clinicians. New information regarding the randomized controlled trial ANEXXA-I, which was halted due to andexanet alfa efficacy, provides additional information supporting reversal therapy for severe bleeding.

0 Comments

Tweet Share

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the anticoagulated patient. While clinical trial data remain the standard for clinicians, real world data provide important additional information on the use of a particular Repletion or Reversal therapy for these patients.

1 Comments

Tweet Share

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

July 12, 2022

ICH remains deadly and pathways matter but they aren't always what we need and barriers can be overcome with knowledge.

0 Comments

Tweet Share

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

July 5, 2022

Coordinating the necessary care for hemorrhagic patients is complicated- learn the ropes from experts on the UC Stroke Team. "Smoother, faster better" is the name of the game.

0 Comments

Tweet Share

RSS

1 2 3 4 5 6 7 8 9 10 Next Last

Aug 17

The Clock Is Dead - The Reign of Tissue Imaging

Haemin Go posted on 8/17/2021

Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Kyle B. Walsh, MD, MS

While stroke care was once defined by the clock, it is being defined by tissue imaging more and more. Dr. Walsh takes us on a journey to understand the utility of tissue-based imaging in stroke care, perfusion imaging in LVO patients and MRI imaging in wake-up strokes. The interface of research and clinical care is tangible in the podcast on cutting edge stroke imaging and tissue-based decision-making in acute stroke patients.

Podcast, Pre-Hospital, Time From Stroke, 01_< 6 hrs, 02_6-24 hrs, 03_>24 hrs, 04_Unknown, Topics, Controversies, EBM, LKW, Types Of Content, Podcast, Care Team, EMS, HEMS, Mobile Stroke Unit, ED First Patient Contact, Care Team, EM, Neuro, Nursing, Pharm, Stroke Team, Time From Stroke, 01_< 6 hrs, 02_6-24 hrs, 03_>24 hrs, 04_Unknown, Topics, Controversies, CT Image, EBM, LKW, Tx Approach, Types Of Content, Podcast, Testing, Triage & Disability Assessment, Care Team, EM, Neuro, Neurorad, Stroke Team, Time From Stroke, 01_< 6 hrs, 02_6-24 hrs, 03_>24 hrs, 04_Unknown, Topics, Controversies, EBM, Imaging, Types Of Content, Podcast, Imaging & Diagnostics, Care Team, EM, Neuro, Neurorad, Stroke Team, Time From Stroke, 01_< 6 hrs, 02_6-24 hrs, 03_>24 hrs, 04_Unknown, Topics, Best Practices, Controversies, Diagnostics, EBM, Tissue vs Time, Types of Content, Podcast, Fibrinolytic Therapy, Care Team, EM, Hosp Med, Neuro, Neurophys, Neurosurg, Stroke Team, Diagnosis, IS, Topics, Combo Rx, Controversies, EBM, Intra-arterial Rx, IV Rx, Lytic Therapy, New Approaches, Physiology, Treatments, Types of Content, Podcast, Endovascular Therapy, Care Team, EM, Neuro, Neurorad, Neurosurg, Stroke Team, Diagnosis, IS, Topics, Controversies, EBM, Endovascular Rx, Novel Tx, Pat. Selection, Standard Care, Types of Content, Podcast, ICU & Critical Care, Care Team, Critical Care, Hosp Med, Neuro, Stroke Team, Diagnosis, IS, Topics, Controversies, EBM, SOC, Types of Content, Podcast, Post-ICU Care, Diagnosis, IS, Types of Content, Podcast, Content Types, Podcast

0 Comments

Tweet Share

0 Comments

Please login or register to post comments.

MRI In Acute Stroke: Promises and Pitfalls

April 12, 2022

MRI imagining is becoming more available in acute settings; understanding MRI in stroke is critical to staying ahead of the curve.

0 Comments

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the...

1 Comments

Posterior Circulation Horror Stories: How To Save the Day and Your Patient

March 22, 2022

Posterior circulation strokes are often devastating. The diagnostics are different and the treatments are evolving. If you care for stroke patients, this...

0 Comments

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

July 28, 2023

Real World studies can provide the foundational support necessary for clinicians to effectively manage anticoagulated patients with severe, often...

0 Comments

When Should We Consider Restarting Anticoagulation in DVT, PE and Afib Patients? What Should I Tell the Family To Be on the Look-Out for Once They Are Discharged?

February 1, 2022

When patients need anticoagulation but have had an ICH or large ischemic stroke, when do we restart anticoagulation? When, if ever, is it safe?

0 Comments

First Previous 1 2 3 4 5 6 7 8 9 10 Next

STAY CONNECTED

Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.

ABOUT THE STROKE JOURNEY

The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.

OUR PARTNERS

The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.

How do we implement ANNEXXa-I into our Clinical Practice?

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

Archive

Categories

More Entries

The Clock Is Dead - The Reign of Tissue Imaging

Please login or register to post comments.